SER

NYSEAMERICAN 已收盘

Serina Therapeutics

1.12 USD
▼-0.08-6.67%
盘后 1.12 0.00%
2026-11-20
市值
$29.76M
市盈率
—
EPS
-1.68
股息率
—
52 周区间
1.06 – 4.26
成交量
62.10K
Beta
0.15
目标价
9.50
52W 低 1.0652W 高 4.26
价格走势

公司简介

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson’s disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson’s and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it ...